NORTHWEST BIOTHERAPEUTICS INC (NWBO) Operating cash flow 2016–2025
NORTHWEST BIOTHERAPEUTICS INC (NWBO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$44.8MFY2025 · since FY2016: -$55.7M → -$44.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$44.8M | +21.5% |
| FY2024 | -$57.0M | -6.3% |
| FY2023 | -$53.6M | -1.6% |
| FY2022 | -$52.8M | -37.8% |
| FY2021 | -$38.3M | -19.3% |
| FY2020 | -$32.1M | -0.7% |
| FY2019 | -$31.9M | +7.9% |
| FY2018 | -$34.6M | +5.2% |
| FY2017 | -$36.5M | +34.4% |
| FY2016 | -$55.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice